294 related articles for article (PubMed ID: 9213225)
1. Human papillomavirus (HPV) 16 E6 sensitizes cells to atractyloside-induced apoptosis: role of p53, ICE-like proteases and the mitochondrial permeability transition.
Brown J; Higo H; McKalip A; Herman B
J Cell Biochem; 1997 Aug; 66(2):245-55. PubMed ID: 9213225
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus type 16 E6 and HPV-16 E6/E7 sensitize human keratinocytes to apoptosis induced by chemotherapeutic agents: roles of p53 and caspase activation.
Liu Y; McKalip A; Herman B
J Cell Biochem; 2000 May; 78(2):334-49. PubMed ID: 10842327
[TBL] [Abstract][Full Text] [Related]
3. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
[TBL] [Abstract][Full Text] [Related]
4. HPV E6 antisense induces apoptosis in CaSki cells via suppression of E6 splicing.
Cho CW; Poo H; Cho YS; Cho MC; Lee KA; Lee SJ; Park SN; Kim IK; Jung YK; Choe YK; Yeom YI; Choe IS; Yoon DY
Exp Mol Med; 2002 May; 34(2):159-66. PubMed ID: 12087999
[TBL] [Abstract][Full Text] [Related]
5. Proteasome inhibitor MG132 sensitizes HPV-positive human cervical cancer cells to rhTRAIL-induced apoptosis.
Hougardy BM; Maduro JH; van der Zee AG; de Groot DJ; van den Heuvel FA; de Vries EG; de Jong S
Int J Cancer; 2006 Apr; 118(8):1892-900. PubMed ID: 16287099
[TBL] [Abstract][Full Text] [Related]
6. Caveolin-1 expression is down-regulated in cells transformed by the human papilloma virus in a p53-dependent manner. Replacement of caveolin-1 expression suppresses HPV-mediated cell transformation.
Razani B; Altschuler Y; Zhu L; Pestell RG; Mostov KE; Lisanti MP
Biochemistry; 2000 Nov; 39(45):13916-24. PubMed ID: 11076533
[TBL] [Abstract][Full Text] [Related]
7. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297
[TBL] [Abstract][Full Text] [Related]
8. Specific HIV protease inhibitors inhibit the ability of HPV16 E6 to degrade p53 and selectively kill E6-dependent cervical carcinoma cells in vitro.
Hampson L; Kitchener HC; Hampson IN
Antivir Ther; 2006; 11(6):813-25. PubMed ID: 17310826
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
Munagala R; Aqil F; Jeyabalan J; Gupta RC
Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
[TBL] [Abstract][Full Text] [Related]
10. Role of the mitochondrial membrane permeability transition (MPT) in rotenone-induced apoptosis in liver cells.
Isenberg JS; Klaunig JE
Toxicol Sci; 2000 Feb; 53(2):340-51. PubMed ID: 10696782
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid.
Hougardy BM; van der Zee AG; van den Heuvel FA; Timmer T; de Vries EG; de Jong S
Gynecol Oncol; 2005 May; 97(2):353-64. PubMed ID: 15863130
[TBL] [Abstract][Full Text] [Related]
12. Co-localization of the tumor-suppressor protein p53 and human papillomavirus E6 protein in human cervical carcinoma cell lines.
Liang XH; Volkmann M; Klein R; Herman B; Lockett SJ
Oncogene; 1993 Oct; 8(10):2645-52. PubMed ID: 8397367
[TBL] [Abstract][Full Text] [Related]
13. Chemoradiation of cervical cancer cells: targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand.
Koivusalo R; Krausz E; Ruotsalainen P; Helenius H; Hietanen S
Cancer Res; 2002 Dec; 62(24):7364-71. PubMed ID: 12499281
[TBL] [Abstract][Full Text] [Related]
14. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo.
Ahn WS; Bae SM; Lee KH; Lee JM; Namkoong SE; Chun HJ; Kim CK; Kim YW
Gynecol Oncol; 2004 Feb; 92(2):611-21. PubMed ID: 14766255
[TBL] [Abstract][Full Text] [Related]
15. Human papilloma virus 16 E6 RNA interference enhances cisplatin and death receptor-mediated apoptosis in human cervical carcinoma cells.
Tan S; Hougardy BM; Meersma GJ; Schaap B; de Vries EG; van der Zee AG; de Jong S
Mol Pharmacol; 2012 May; 81(5):701-9. PubMed ID: 22328720
[TBL] [Abstract][Full Text] [Related]
16. Wogonin induces apoptosis by suppressing E6 and E7 expressions and activating intrinsic signaling pathways in HPV-16 cervical cancer cells.
Kim MS; Bak Y; Park YS; Lee DH; Kim JH; Kang JW; Song HH; Oh SR; Yoon DY
Cell Biol Toxicol; 2013 Aug; 29(4):259-72. PubMed ID: 23955116
[TBL] [Abstract][Full Text] [Related]
17. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus 18 oncoproteins E6 and E7 enhance irradiation- and chemotherapeutic agent-induced apoptosis in p53 and Rb mutated cervical cancer cell lines.
Kilic G; Cardillo M; Ozdemirli M; Arun B
Eur J Gynaecol Oncol; 1999; 20(3):167-71. PubMed ID: 10410876
[TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide induces cervical cancer apoptosis, but specifically targets human papillomavirus-infected cell populations.
Wen X; Li D; Zhang Y; Liu S; Ghali L; Iles RK
Anticancer Drugs; 2012 Mar; 23(3):280-7. PubMed ID: 22245994
[TBL] [Abstract][Full Text] [Related]
20. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
